Routine Vaccinations Linked with Lower Alzheimer’s Risk

Translate to Spanish or other 102 languages!

Some vaccines are linked to a lower risk of Alzheimer’s. Image for illustration purposes
Some vaccines are linked to a lower risk of Alzheimer’s. Image for illustration purposes

Medical News Today

- Advertisement -
  • Recent research from UTHealth Houston suggests that the administration of some vaccinations, including those for tetanus, diphtheria, pertussis (whooping cough), shingles (herpes zoster), and pneumococcus, are associated with a reduced risk of developing Alzheimer’s disease.
  • Previous research revealed that individuals who had received at least one influenza vaccine had a 40% lower probability of developing Alzheimer’s disease compared to those who had not received any vaccination, leading researchers to investigate other vaccines.
  • These new findings are particularly notable as they point to a practical and accessible way for Alzheimer’s prevention, emphasizing the advantages of routine adult vaccinations.

In a new study whose results appeared in the Journal of Alzheimer’s Disease, researchers found that several vaccines commonly given to adults were similarly linked to a decreased likelihood of developing Alzheimer’s disease.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/routine-vaccinations-linked-with-lower-alzheimers-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.

Identify the Early Warning Signs of Memory Loss

We’ve all lost our keys or forgotten a name every now and then, but when does forgetfulness signal something more serious?

How to Keep Your Thanksgiving Dinner Safe

As families across the country prepare for Thanksgiving, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is reminding consumers to take simple steps that will keep their holiday meals safe and enjoyable.
- Advertisement -